Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Bridging the Nervous-Endocrine System and Immune Response, in Human Chagas Disease Pathology

González FB., Dinatale B., Savino W., Bottasso OA., Pérez AR.

Narrative Review on Immune Modulation, published in Neuroimmunomodulation (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Neuroimmunomodulation (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41069094
PMCID
PMC12659659
DOI
10.1159/000548813

Abstract (original English)

Background: Chronic Chagas disease can affect multiple organs, most notably the heart and gastrointestinal tract, and in some cases, the nervous system. However, the underlying pathophysiological mechanisms of this parasitic infection remain incompletely understood. Summary: Evidence from studies in both mice with acute Trypanosoma cruzi (T. cruzi) infection and in patients with Chagas disease has revealed a range of immune-neuroendocrine alterations and metabolic disruptions. In this review, we highlight key findings in human Chagas disease related to these abnormalities and discuss their potential contributions to disease pathogenesis. Key Messages: In the context of chronic Chagas disease, the neuroendocrine-immune axis operates as a dynamic interface, integrating systemic immune-endocrine processes with localized responses in the central nervous system (CNS), with each component influencing disease advancement and organ-specific pathology through distinct yet interconnected mechanisms. .

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Endocrine SystemNeurosecretory SystemsCentral Nervous SystemAnimalsHumansTrypanosoma cruziChagas DiseaseNeuroimmunomodulation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research